Satoshi Ikehara
Toho University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Satoshi Ikehara.
International Journal of Cardiology | 2013
Shohei Ogata; Adriana H. Tremoulet; Yuichiro Sato; Kayla Ueda; Chisato Shimizu; Xiaoying Sun; Sonia Jain; Laura Silverstein; Annette L. Baker; Noboru Tanaka; Yoshihito Ogihara; Satoshi Ikehara; Shinichi Takatsuki; Naoko Sakamoto; Tohru Kobayashi; Shigeto Fuse; Tomoyo Matsubara; Masahiro Ishii; Tsutomu Saji; Jane W. Newburger; Jane C. Burns
OBJECTIVE It has been claimed that the aneurysm rate for Kawasaki disease (KD) patients in Japan is lower than in the U.S. However it has been difficult to compare coronary artery (CA) outcomes between the two countries because of different definitions for CA abnormalities. Therefore, we compared CA internal diameters between Japanese and U.S. KD patients using standard definitions and methods. STUDY DESIGN We retrospectively reviewed CA outcomes in 1082 KD patients from 2 centers in the U.S. and 3 centers in Japan and compared Z-max scores (maximum internal diameter for the left anterior descending or right coronary artery expressed as standard deviation units from the mean (Z-score) normalized for body surface area) obtained within 12 weeks after onset and calculated using two different regression equations from Canada (Dallaire) and Japan (Fuse). We defined a Z-max of < 2.5 as normal and a Z-max of ≥ 10 as giant aneurysm. RESULT The median Z-max for the U.S. and Japanese subjects was 1.9 and 2.3 SD units, respectively (p < 0.001). There was no significant difference in rates of patients with Z-max ≥ 5.0 between the countries. In a multivariable model adjusting for age, sex, and treatment response, being Japanese was still associated with a higher Z-max score. CONCLUSION Previously reported differences in aneurysm rates between Japan and the U.S. likely resulted from use of different definitions and nomenclature. Adoption of Z-scores as a standard for reporting CA internal diameters will allow meaningful comparisons among different countries and will facilitate international, collaborative clinical trials.
The Journal of Pediatrics | 2017
Shinichi Takatsuki; Tomotaka Nakayama; Satoshi Ikehara; Hiroyuki Matsuura; David Dunbar Ivy; Tsutomu Saji
Objectives To evaluate the clinical utility of pulmonary artery capacitance index (PACi) in the assessment of disease severity and prognostic value in children with idiopathic and heritable pulmonary arterial hypertension (PAH). Study Design PACi is defined as the ratio of stroke volume index over pulmonary pulse pressure. A retrospective study was performed to compare PACi, brain natriuretic peptide (BNP), 6‐minute walk distance, New York Heart association (NYHA) functional class, and adverse outcomes (hospitalization due to heart failure, lung transplantation, and cardiac mortality) in 72 Japanese children (10 ± 3.6 years) with idiopathic and heritable PAH. Results PACi had significant correlations with pulmonary vascular resistance index (r =−0.73, P < .0001), BNP levels (r = −0.40, P = .0008), and 6‐minute walk distance (r = 0.57, P < .05). Statistically significant differences in PACi were observed between NYHA functional class II vs combined III and IV (median; 1.1 vs 0.6 mL/mm Hg/m2, respectively, P < .05). There were 25 of 72 (35%) children who had an adverse event including initiation of hospitalization due to heart failure, lung transplantation, and death. Cumulative event‐free survival rate was significantly lower when PACi was <0.85 mL/mm Hg/m2 (log‐rank test, P < .0001). Conclusions PACi correlated with BNP and NYHA functional class and may serve as a strong prognostic marker in children with idiopathic and heritable PAH.
Circulation | 2017
Satoshi Ikehara; Shinichi Takatsuki; Tomotaka Nakayama; Kazuyuki Naoi; Hiroyuki Matsuura; Tsutomu Saji
BACKGROUND Few studies have investigated the clinical impact of pulmonary artery (PA) dilatation on outcomes in pediatric pulmonary arterial hypertension (PAH).Methods and Results:This study investigated the clinical outcomes of idiopathic or heritable PAH in 66 children aged <18 years at diagnosis. Main PA/thorax (MPA/T) ratio was measured on chest radiography in PAH patients. Patients were divided into 2 groups based on MPA/T ratio, and compared with a control group of 166 age- and gender-matched healthy children. Group A had higher MPA/T ratio than normal, and group B had normal MPA/T ratio. Composite outcomes included cardiac death, lung transplantation, and hospitalization due to heart failure. Group A consisted of 27 patients and group B, 39 patients. At diagnosis, group A had significantly higher brain natriuretic peptide (BNP), cardiothoracic ratio, PA pressure, and pulmonary vascular resistance index compared with group B. The number of patients with New York Heart Association (NYHA) functional class III and IV was significantly higher in group A than in group B. Cumulative event-free survival rate was significantly lower in group A. CONCLUSIONS MPA dilatation correlated with BNP, NYHA functional class, and hemodynamics with regard to disease severity, and may be a potential prognostic factor in pediatric idiopathic and heritable PAH.
Journal of Pediatric Endocrinology and Metabolism | 2011
Mari Satoh; Keiko Aso; Satoshi Ikehara; Yumiko Komine; Tsutomu Saji
Abstract A 3-year-old girl with Graves’ disease developed a generalized convulsion as a result of hypoglycemia (25 mg/dL). At the time of the hypoglycemic seizure, her plasma adrenocorticotropin (ACTH) level (1460 pg/mL) was extremely high, but her serum cortisol level (28.4 μg/dL) was relatively low given the severe stress. The cortisol-releasing hormone (CRH) provocation test done after thyroid function had improved revealed normal ACTH and cortisol responses. Since there was no other cause of hypoglycemia, such as hyperinsulinemia, long-term starvation, suddenly advanced emaciation, or prolonged fasting, it was suspected that the transient adrenal hyporesponsiveness was the main cause of hypoglycemia.
Circulation | 2010
Mari Satoh; Keiko Aso; Tomotaka Nakayama; Kazuyuki Naoi; Satoshi Ikehara; Yumiko Uchino; Hiromitsu Shimada; Shinichi Takatsuki; Hiroyuki Matsuura; Tsutomu Saji
Pediatric Cardiology | 2018
Shinichi Takatsuki; Shun Yanai; Satoshi Ikehara; Tomotaka Nakayama; Horoyuki Matsuura
Pediatric Cardiology and Cardiac Surgery | 2017
Shinichi Takatsuki; Satoshi Ikehara; Tomotaka Nakayama; Hiroyuki Matsuura; Tsutomu Saji
Pediatric Cardiology and Cardiac Surgery | 2016
Hiroyuki Matsuura; 松裏裕行; Kazuyuki Naoi; 直井和之; Satoshi Ikehara; 池原聡; Shinichi Takatsuki; 高月晋一; Tomotaka Nakayama; 中山智孝; Hidehiko Hara; 原英彦; Tsutomu Saji; 佐地勉; Farhouch Berdjis; FarhouchBerdjis
Pediatric Cardiology and Cardiac Surgery | 2015
Tsutomu Saji; Tomotaka Nakayama; Shinichi Takatsuki; Satoshi Ikehara; Hiromitsu Shimada; Kazuyuki Naoi; Mari Sato; Hiroyuki Matsuura
Circulation | 2015
Reiko Kawai; Shinichi Takatsuki; Tomotaka Nakayama; Tomoka Sawa; Shun Yanai; Kazuyuki Naoi; Satoshi Ikehara; Hiroyuki Matsuura; Akira Ohara; Tsutomu Saji